Dysphagia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. System Development Phase (Cross-sectional Survey Study) (1) Patients: Water Swallowing Test grade = 3, or physician-ordered dysphagia diet; etiologies include but are not limited to stroke, neurodegenerative diseases, postoperative or post-radiotherapy head and neck tumors; Age = 18 years; Patient or family member possesses language communication ability (can understand and respond to simple directive questions); Voluntarily signs informed consent form. 2. System Development Phase (Qualitative Study) (1) Patients: Same as "System Development Phase (Cross-sectional Survey Study)". (2) Follow-up Management Personnel: Hospital staff currently employed in departments (e.g., Neurology, Rehabilitation Medicine, etc.) that routinely treat or manage dysphagia patients; Positions include nursing managers, clinical nurses, dedicated follow-up personnel, etc., who are directly involved in patient care and rehabilitation guidance; = 5 years of relevant work experience; Understands the study purpose and voluntarily signs informed consent form. 3. Usability Evaluation Phase (Platform Pilot Operation) Patients: Same as "System Development Phase (Cross-sectional Survey Study)". 4. Usability Evaluation Phase (Qualitative Study + Cross-sectional Survey Study) (1) Patients: Have participated in and completed Part II "(A) Platform Testing" of this project, and have completed at least one full system follow-up interaction; Other criteria are the same as "System Development Phase (Cross-sectional Survey Study)". (2) Follow-up Management Personnel: Positions include nursing managers, senior clinical nurses, dedicated follow-up personnel, etc., who have been directly or indirectly involved in the deployment, management, monitoring, or patient guidance of this system during the earlier pilot operation phase; Other criteria are the same as "System Development Phase (Qualitative Study)".
Exclusion criteria
Exclusion criteria: 1. System Development Phase (Cross-sectional Survey Study) (1) Patients: Patients with severe cognitive or psychiatric impairment, or with psychiatric disorders (e.g., schizophrenia, major depressive disorder) that may affect adherence; patients or their family members with poor cooperation; concurrent participation in other clinical trials involving swallowing rehabilitation or digital health interventions. 2. System Development Phase (Qualitative Study) (1) Patients: Same as the exclusion criteria for the "System Development Phase (Cross-sectional Survey Study)". (2) Follow-up Management Personnel: Personnel planning to resign, take long-term leave, or undertake external training within the next month, making it likely they cannot complete the research interviews; Personnel concurrently serving as principal investigators or coordinators in other clinical studies directly related to AI-powered follow-up systems, which may create conflicts of interest or introduce bias. 3. Usability Evaluation Phase (Platform Pilot Operation) Patients: Same as the exclusion criteria for the "System Development Phase (Cross-sectional Survey Study)". 4. Usability Evaluation Phase (Qualitative Study + Cross-sectional Survey Study) (1) Patients: Presence of severe cognitive impairment, psychiatric disorders, or any other condition deemed by the investigator to potentially affect the provision of valid feedback; a system utilization rate below 30% during the platform testing period (e.g., fewer than 2 answered calls out of 6 preset intelligent follow-up call attempts). (2) Follow-up Management Personnel: Personnel who did not practically operate or use the management backend or related functions of this follow-up system during the pilot operation phase. Personnel planning to take leave, undertake external training, or resign during the research interview phase, and thus unable to cooperate in completing the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intelligent Follow-up Needs;System Usability;User Satisfaction; | — |
Countries
China
Contacts
Beijing Tiantan Hospital, Capital Medical University